Join Cato Research As It Hosts Two Spectacular Wine Tastings During DIA and BIO International Convention in San Diego, CA, USA

Cato Research (CATO) will host two wine tastings this month of June in parallel with two major life science industry events: DIA and BIO International in which CATO experts will also be attending these events.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Cato Research 25 Years - Navigating Decades of Successful Life Science Research & Development

Cato Research 25 Years - Navigating Decades of Successful Life Science Research & Development

San Diego, CA (PRWEB) June 10, 2014

Cato Research (CATO) will host two wine tastings this month of June in parallel with two major life science industry events: DIA and BIO International in which CATO experts will also be attending these events.

Join Cato Research at the historical and haunted William Heath Davis House Museum located at 410 Island Avenue, San Diego, California, United States, for an evening of fine wines highly rated by the Wine Advocate or the Wine Spectator, accompanied by delectable hors d'oeuvres. Reserve early, as space is limited:

CATO’s DIA Wine Tasting Event - Tuesday, 17 June, 2014
CATO’s BIO International Wine Tasting Event - Tuesday, 24 June, 2014
5:00 - 8:00 p.m. at the Historical and Haunted William Heath House
410 Island Avenue, San Diego, California, United States

For more information or to register for these events, please visit the web address below: http://www.cato.com/marketing/2014/2014-Wine-Tasting_DIA_BIO-CRSD.html.

Attending experts include:
Allen Cato, M.D., Ph.D., Cofounder and Chief Executive Officer of Cato Research and Principal of Cato BioVentures; Lynda Sutton, B.S., Cofounder, President and Chief Regulatory Officer of Cato Research and Principal of Cato BioVentures; Daniel Pharand, C.P.A., C.A., Chief Financial Officer of Cato Research and Principal of Cato BioVentures; Rainer Gerhard Schuckelt, Ph.D., Managing Director of Central and Eastern Europe of Cato Research; Jo Cato, Ph.D., Chief Operating Officer of Cato Research and Vice President of Cato BioVentures; David Gee, Vice President of Business Development of Cato Research; and Kris Dyszynski, B.A., Business Developer of Cato Research.
These experts, along with other CATO representatives, will be rotating at the wine tastings and also participating in networking events and attend one-on-one partnering meetings during DIA and BIO International.

To set up a meeting with any of CATO’s attending experts, please call 919-361-2286 or send an email to dgee(at)cato(dot)com.

About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. With a staff of approximately 300 and offices located in the United States, Europe, Canada, Israel, and South Africa, the Cato Research team consistently demonstrates an unsurpassed level of responsiveness, flexibility, attention to detail, and passion for bringing their clients’ products to market with speed and cost effectiveness. For more information about Cato Research, visit http://www.cato.com.

About Cato BioVentures
Cato BioVentures is the venture capital affiliate of Cato Research, a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepreneurs, academic institutions, and a broad base of biotechnology and pharmaceutical companies to advance a robust portfolio of successful product development programs. Through strategic CRO service agreements with Cato Research, Cato BioVentures has invested its CRO Service Capital™ in innovative therapeutics, medical devices, and stem cell technologies that improve the pharmaceutical industry’s research and development productivity. If strategic outsourcing for development, regulatory, and clinical support is a core component of a company’s business plan, then Cato BioVenture’s investment model can make a positive difference in the company’s overall success. For more information about Cato BioVentures, call 919-361-2286 or visit http://www.catobioventures.com.

For more information, please contact:
Cato Research
Phone: 919-361-2286
http://www.cato.com
# # #


Contact

  • Jessica Bliven
    Cato Research
    9197681230
    Email
Follow us on: Contact's Google Plus

Attachments

You are Invited to Two Spectacular CATO Wine Tastings You are Invited to Two Spectacular CATO Wine Tastings

You are Invited to Two Spectacular CATO Wine Tastings